FDA's Approval Of A Cheaper Drug For Hepatitis C Will Likely Expand Treatment
Mavyret, recently approved by the Food And Drug Administration, can cure hepatitis C in eight weeks, at a cost of $26,400. Though still expensive, that's well below the price of other options.
Read more on NPR
Health Care
October 4, 2017 at 04:00PM
Blog Beauty 24/7
Không có nhận xét nào:
Đăng nhận xét